Prelude Capital Management’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
ACM
OCMI
Prelude Capital Management's ASPN Position: Q3 2026 in Review
Prelude Capital Management sold out of Aspen Aerogels (ASPN) in Q3 2026, closing a stake of 13,911 shares — an estimated $88.2K sold.
Prelude Capital Management first reported a position in ASPN in Q3 2019 and held it in 10 quarters. The position peaked at $324K in Q4 2022. 186 funds tracked by Wall St. Rank hold ASPN as of Q3 2026.
- Prelude Capital Management reported no remaining Aspen Aerogels position as of Q3 2026 after selling out during the quarter.
- Prelude Capital Management sold 13,911 Aspen Aerogels shares in Q3 2026, an estimated $88.2K.
- Prelude Capital Management first reported a position in Aspen Aerogels in Q3 2019 and held it in 10 quarters.
- Prelude Capital Management's Aspen Aerogels position peaked at $324K in Q4 2022.
- 186 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.